Pharmaceutical Anti Counterfeiting Technologies 2014-2024

Pharmaceutical Anti-counterfeiting
Technologies: Market Analysis
2014-2024

©notice
This material is copyright by visiongain. It is against the law to reproduce any of this material without the prior written agreement of visiongain. You cannot photocopy, fax, download to database or duplicate in any other way any of the material contained in this report. Each purchase and single copy is for personal use only.

Contents
1. Executive Summary
1.1 Market Highlights
1.2 Overview of the Report Content
1.3 Research and Analysis Methods
1.4 Glossary of Terms Related to Pharmaceutical Anti-counterfeiting Technologies

2. Introduction to Pharmaceutical Counterfeiting
2.1 Drug Counterfeiting: A Thorn in the Side of the Pharma Industry
2.1.1 Regional Differences Hindering Information Exchange
2.1.2 Rising Counterfeiting Incidents in Developed Regions
2.2 The Most Commonly Counterfeited Drugs
2.3 Types of Counterfeit Drugs
2.3.1 Substandard Pharmaceutical Products as Counterfeits
2.3.2 Global Outsourcing of Active Pharmaceutical Ingredients (APIs)
2.3.2.1 Heparin Contamination
2.3.2.2 Stricter Enforcement needed for API Control
2.4 Why are Drugs Counterfeited?
2.4.1 Methods of Producing Pharmaceutical Counterfeits
2.4.2 Moving Counterfeits into the Pharmaceutical Supply Chain
2.4.3 Corruption Within the Pharmaceutical Distribution System
2.5 The Internet and its Role in Pharmaceutical Counterfeiting
2.5.1 Online Pharmacies: A Cheap Distribution System for Pharma Counterfeits
2.5.2 Legal Online Pharmacies: A Convenient and Quick Way of Dispensing Medication
2.5.3 Verifying the Authenticity of Online Pharmacies
2.6 Pharmaceutical Counterfeiting: The Global Costs
2.6.1 The Impact of Pharmaceutical Counterfeiting on Consumers
2.6.2 The Impact of Counterfeiting on Healthcare Providers
2.6.3 The Impact of Counterfeiting on Pharma Manufacturers

www.visiongain.com

Contents
2.6.4 The Impact of Pharmaceutical Counterfeiting on Governments
2.6.5 The Impact of Counterfeiting on the Global Pharmaceutical Industry
2.6.5.1 Operation Pangea: Europol’s Fight Against Counterfeiting
2.6.5.2 Legislative Deficiencies Aiding Counterfeiting Operations
2.7 Factors Fuelling Pharmaceutical Counterfeiting
2.7.1 An Erratic Supply or Shortage of Drugs Promotes Counterfeiting
2.7.2 Price Differentials and High Price Medicines Drive People to Cheaper Counterfeit
Alternatives
2.7.3 Drug Misuse Creates a Market for Counterfeiting
2.7.4 Trade through Free-Trade Zones/Free Ports Is an Important Route for Counterfeiters
2.7.5 The Trade of Pharmaceuticals through Several Intermediaries Helps Hide Counterfeit
Drugs
2.7.6 Counterfeiters Target Developed Markets
2.7.7 Parallel Trade – a Counterfeiting Route in Europe

3. Leading Technologies and Applications
3.1 Passive Technologies
3.1.1 Security Inks as Anti-counterfeiting Technologies
3.1.2 Holograms as Anti-counterfeiting Technologies
3.1.3 Visual Inspection as the First Line of Defence Against Drug Counterfeiting
3.1.4 Overt and Hidden Imaging
3.2 Active Technologies
3.2.1 Electromagnetic Tags – Radio Frequency Identification (RFID) as Anti-counterfeiting
Technologies
3.2.2 Taggants as Anti-counterfeiting Technologies
3.2.3 Mass Encoding Technology
3.2.3.1 Digital Mass Serialisation Technology (DMS)
3.2.3.2 Digital Mass Encryption (DME)
3.2.3.3 Barcode Applications: Serialisation is Key

www.visiongain.com

Contents
4. Leading Companies in the Pharmaceutical Anti-counterfeiting
Technologies Market
4.1 3M: A Diversified Technology Multinational
4.2 Alien Technology: RFID Technology Specialist
4.3 AlpVision: Cryptoglyph Security Solution
4.3.1 Fingerprint: A ‘Read Only’ Technology
4.3.2 Krypsos Platform
4.3.3 Cryptoglyph
4.3.4 AlpVision: Integration of Phone Applications Important for Future Growth
4.4 Angstrom Technologies – Security Inks
4.5 Authentix: Product Authentication and Brand Protection
4.5.1 Product-specific Track-and-Trace Solutions
4.5.2 Packaging Solutions
4.6 Avery Dennison: RFID Technologies Expert
4.7 Colorcon
4.7.1 Colorcon’s Taggants: On-Dose ID
4.7.2 Colorcon’s Brand Enhancement Service
4.8 Chesapeake: Acquired by The Caryle Group
4.9 Covectra
4.9.1 Covectra’s Authenti-Track System for Product Tracing
4.9.2 Covectra’s ControlTrack System for Combating Opioid Drug Diversion
4.10 Everest Holovisions
4.11 InkSure Technologies: Leader in Cloud-based Authentication
4.12 Intermec: A Workflow Performance Company
4.12.1 Automatic Information Data Capture
4.12.2 Will Recent Acquisitions Spell an Uncertain Future?
4.13 NanoGuardian
4.13.1 NanoCodes: Data Carriers of Limitless Potential

www.visiongain.com

Contents
4.13.2 NanoGuardian’s Global Licensing Agreement with Capsugel
4.13.3 The Closed-Loop Protection System
4.13.4 Major Players Showing Interest In NanoGuardian’s Technologies
4.14 ThermoFisher Scientific
4.14.1 Acquisition of Ahura Scientific
4.14.2 Continous Growth and Expansion into Emerging Markets
4.14.3 ThermoFisher Scientific’s TruScan Technology
4.15 TruTag Technologies
4.15.1 TruTag’s Silica Microtag Technology
4.16 UPM Raflatac
4.17 Zebra Technologies

5. Global Pharmaceutical Anti-counterfeiting Technologies Market
2014-2024
5.1 Pharmaceutical Anti-counterfeiting Technologies: Market Overview
5.1.1 Size of the Pharmaceutical Anti-counterfeiting Technologies Market in 2012 and
2013
5.1.2 Global Pharmaceutical Anti-counterfeiting Technologies Market: Growth Trends
5.1.3 Global Pharmaceutical Anti-counterfeiting Technologies Market Forecast 2012-2017
5.1.4 Global Pharmaceutical Anti-counterfeiting Technologies Market Forecast 2017-2024
5.1.5 Changing Market Shares by Sector, 2012-2024
5.2 Pharmaceutical RFID Market Forecast 2012-2024
5.3 Pharmaceutical Security Printing Market Forecast 2012-2024
5.4 Pharmaceutical Taggants Market Forecast 2012-2024
5.5 Pharmaceutical Hologram/OVD Market Forecast 2012-2024
5.6 Other Pharmaceutical Anti-counterfeiting Technologies Market Forecast 2012-2024

www.visiongain.com

Contents
6. Leading National Markets 2014-2024
6.1 Pharmaceutical Counterfeiting: A Global Conundrum
6.1.1 How Will National Market Shares Change to 2024?
6.2 Regional Pharmaceutical Anti-counterfeiting Market Forecast, 2014-2024
6.2.1 The US Market
6.2.2 EU5: Europe’s Leading Anti-counterfeiting Technology Markets
6.2.3 Japan: Uptake of Key Technologies Important for Market Growth
6.2.4 China: Set to See High Growth Rates Continue Until 2017
6.2.5 India: New Mandates will Help Deter Counterfeiters
6.2.5.1 Collaboration with the WHO will Help Regain Consumer Confidence in
Pharma Products
6.2.6 Brazil: South America’s Largest Pharmaceutical Market
6.2.7 Russia: Highest Per-Capita Spending on Healthcare of All the BRIC Nations

7. Issues Affecting the Pharmaceutical Anti-counterfeiting
Technologies Market
7.1 SWOT Analysis of the Pharmaceutical Anti-counterfeiting Technologies Market, 2014-2024
7.2 Strengths
7.2.1 Growing Interest from Pharmaceutical Companies in Tackling Counterfeiting
7.2.1.1 AstraZeneca
7.2.1.2 GlaxoSmithKline
7.2.1.3 Johnson & Johnson
7.2.1.4 Novartis
7.2.1.5 Pfizer
7.2.1.6 Sanofi
7.2.2 Organisations Promoting the Awareness and Implementation of Anti-Counterfeiting
Solutions

www.visiongain.com

Contents
7.2.2.1 Anti-counterfeiting and Product Protection Programme (A-CAPPP)
7.2.2.2 Anti-counterfeiting Group (ACG)
7.2.2.3 Brazil’s National Health Surveillance Agency (ANVISA)
7.2.2.4 Canadian Anti-counterfeiting Network (CACN)
7.2.2.5 Center for Healthcare Supply Chain Research
7.2.2.6 European Alliance for Access to Safe Medicines (EAASM)
7.2.2.7 European Federation of Pharmaceutical Industries and Associations (EFPIA)
7.2.2.8 International Anti-counterfeiting Coalition (IACC)
7.2.2.9 International Authentication Association (IAA)
7.2.2.10 The Pharmaceutical Security Institute (PSI)
7.2.3 Track-and-Trace Solutions Boosting Supply Chain Efficiency
7.2.4 New Technologies Providing More Comprehesive Anti-Counterfeiting Protection
7.2.5 Litigation Proceedings over Counterfeit Products Affecting Profitability
7.3 Weaknesses
7.3.1 The Lack of Standardisation Across the Industry as a Whole Will Impede Technology
Adoption
7.3.2. Insufficient Quantitative Measurement of the Effectiveness of Anti-counterfeiting
Technologies
7.3.2.1 Complexity of Factors Influencing Drug Revenue Makes Quantifying
Commercial Impact of Anti-counterfeiting Technologies Difficult
7.3.3 Technology Reliability and the Ease of Integration into Manufacturing Processes
7.3.4 Lack of Cooperation Between Various Governmental Organisations Aids Drug
Counterfeiters
7.4 Opportunities
7.4.1 Constantly Evolving Technologies Allows for Product Innovation
7.4.2 Anti-counterfeiting Technologies for the Prevention of Online Fraud
7.5 Threats
7.5.1 The High Volume of Counterfeiting Activities Could Devalue Anti-counterfeiting
Solutions
7.5.2 Developing Countries Lack Infrastructure to Effectively Deal with Counterfeiting
7.5.3 Pace of Innovation May Not Keep up with the Counterfeiters

www.visiongain.com

Contents
7.6 STEP Analysis of the Pharmaceutical Anti-counterfeiting Technologies Market, 2014-2024
7.6.1 Social Factors
7.6.1.1 The Weak Enforcement of Legislation
7.6.1.2 Corruption: A Hindrance to Eradicating Pharmaceutical Counterfeiting
7.6.1.3 Changing Public Perception and Consumer Education
7.6.1.4 Concerns Over Information Privacy
7.6.2 Technological Factors
7.6.2.1 Smartphone Read and Verify: A Customer Empowerment Tool
7.6.2.2 US FDA’s Counterfeit Detection Device
7.6.2.3 UV and IR Inks Being Used Covertly for Increased Security
7.6.2.4 Bokode: A Potential Replacement for Barcodes?
7.6.2.5 SigNature DNA
7.6.3 Economic Factors
7.6.3.1 Implementation Costs of Anti-counterfeiting Technologies
7.6.3.2 Anti-counterfeiting Technologies Require R&D Investment
7.6.4 Political Factors
7.6.4.1 World Health Organization: The IMPACT Programme
7.6.4.2 Anti-Counterfeiting Trade Agreement (ACTA)
7.6.4.3 The Fagan Civil Case: Effects of Litigation on Players in the Drug Supply
Chain
7.6.4.4 Legislations for Supply Chain Security
7.6.4.5 E-pedigree: A Catalyst for Product Serialisation
7.6.4.5.1 E-pedigree: Challenges Involved in Implementation
7.6.4.5.2 EU and the US: Differing Supply Chain Authentication
7.6.4.6 UK MHRA: Falsified Medical Products Strategy
7.6.4.7 The EU’s Falsified Medicines Directive

8. Expert Opinions
8.1 Interview with Dr Fred Jordan, Chief Executive Officer, AlpVision

www.visiongain.com

Contents
8.1.1 Current State of Counterfeiting in the Pharmaceutical Industry
8.1.2 AlpVison’s Key Technologies and Strategies for Combating Counterfeiters
8.1.3 The Future of Anti-counterfeiting Technologies
8.1.4 On Whom do the Responsibilities for Counterfeiting Prevention Lie?
8.1.5 The Major Barriers Facing Implementation of Anti-counterfeiting Technologies
8.1.6 Future Growth Drivers of the Anti-counterfeiting Technologies Market
8.2 Interview with a Spokesperson from a Leading Anti-counterfeiting Technologies Company
Based in the US.
8.2.1 On the Threats Posed by Counterfeit Products
8.2.2 Keeping Up with the Counterfeiters: An Impossible Task?
8.2.3 Duty of Care
8.2.4 DNA Technology: The Innovation Needed to Defeat Counterfeiting?
8.2.5 Future Prospects of the Pharma Anti-counterfeiting Industry

9. Conclusion
9.1 The Pharmaceutical Anti-counterfeiting Technologies Industry 2014-2024
9.2 Government Mandates Will Fuel Growth in the Market
9.3 The US Will Continue to Dominate the Market
9.4 New Directives Will Ensure Track-and-Trace Market Leadership
9.5 European Preference for Mandated 2D Barcode Technology
9.6 Improved Regulation of Online Pharmacies Necessary for Anti-counterfeiting Technologies to
be Effective
9.7 Market Expansion Will be Dependent on the Development of Industry-Wide Standards for the
Use of the Available Technologies

www.visiongain.com

Contents
List of Tables
Table 2.1 Global Reported Incidents of Drug Counterfeiting, 2008-2012
Table 2.2 Classification of Counterfeit Pharmaceutical Products
Table 3.1 Anti-counterfeiting Technologies Used in the Pharmaceutical Industry
Table 3.2 Leading Anti-counterfeiting Security Ink Manufacturers, 2013
Table 3.3 Leading Anti-counterfeiting Holographic Labelling Manufacturers, 2013
Table 3.4 Leading Radio Frequency Identification (RFID) System Manufacturers, 2013
Table 3.5 Leading Pharmaceutical Taggants Manufacturers, 2013
Table 4.1 3M: Revenue ($m) and Revenue Shares (%) by Business Segment, 2012
Table 4.2 Alien Technologies: Types of RFID Readers Produced, 2013
Table 4.3 AlpVision: Products and Applications, 2013
Table 4.4 Angstrom Technologies: Products and Applications, 2013
Table 4.5 Avery Dennison: Revenue ($m) and Revenue Shares (%) by Business Segment, 2012
Table 4.6 Avery Dennison: RFID Products for Use in Pharmaceuticals, 2013
Table 4.7 Colorcon: Product Groups, Sub-groups, and Examples 2013
Table 4.8 Everest Holovision: Products and Applications, 2013
Table 4.9 InkSure Technologies: Products and Applications, 2013
Table 4.10 InkSure Technologies: Historical Revenue ($m, AGR %) 2009-2012
Table 4.11 Intermec: Product Lines and Descriptions, 2013
Table 4.12 Intermec: Historical Revenue ($m, AGR %) 2009-2012
Table 4.13 ThermoFisher Scientific: Historical Revenue ($bn) 2009-2012
Table 4.14 ThermoFisher Scientific: Revenue Shares (%) by Region, 2012
Table 4.15 UPM Raflatac: Product Groups and Descriptions, 2013
Table 4.16 Zebra Technologies: Product Groups and Descriptions, 2013
Table 4.17 Zebra Technologies: Historical Revenue ($m, AGR%) 2009-2012
Table 5.1 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Revenues ($m) and
Market Shares (%) by Sector, 2012
Table 5.2 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Revenue Forecast
($m, AGR%, CAGR%) by Sector, 2012-2017
Table 5.3 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Revenue Forecast

www.visiongain.com

Contents
($m, AGR%, CAGR%) by Sector, 2017-2024
Table 5.4 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Revenue ($m) by
Sector, 2012, 2017, 2024
Table 5.5 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%)
by Sector, 2012, 2017, 2024
Table 5.6 RFID: Revenue Forecast ($m, AGR%, CAGR%), 2012-2024
Table 5.7 Security Printing: Revenue Forecast ($m, AGR%, CAGR%), 2012-2024
Table 5.8 Pharmaceutical Taggants: Revenue Forecast ($m, AGR%, CAGR%), 2012-2024
Table 5.9 Holograms/OVD: Revenue Forecast ($m, AGR%, CAGR%), 2012-2024
Table 5.10 Other Technologies: Revenue Forecast ($m, AGR%, CAGR%), 2012-2024
Table 6.1 The Global Pharmaceutical Anti-counterfeiting Technologies: Revenue Forecast ($m,
AGR%, CAGR%) by Region, 2012-2017
Table 6.2 The Global Pharmaceutical Anti-counterfeiting Technologies: Revenue Forecast ($m,
AGR%, CAGR%) by Region, 2017-2024
Table 6.3 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%)
by Region, 2012, 2017, 2024
Table 6.4 US Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m, AGR%, CAGR%),
2012-2024
Table 6.5 EU5 Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m, AGR%, CAGR%),
2012-2024
Table 6.6 Japanese Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m, AGR%,
CAGR%), 2012-2024
Table 6.7 Chinese Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m, AGR%,
CAGR%), 2012-2024
Table 6.8 Indian Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m, AGR%,
CAGR%), 2012-2024
Table 6.9 Brazilian Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m, AGR%,
CAGR%), 2012-2024
Table 6.10 Russian Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m, AGR%,
CAGR%), 2012-2024
Table 7.1 SWOT Analysis of the Pharmaceutical Anti-counterfeiting Technologies Industry, 2014-

www.visiongain.com

Contents
2024
Table 7.2 Selected Instances of Counterfeiting Activities, 2012-2013
Table 7.3 Selected Instances of Counterfeiting Activities, 2009-2011
Table 7.4 STEP Analysis for the Pharmaceutical Anti-counterfeiting Technologies Industry, 20142024

www.visiongain.com

Contents
List of Figures
Figure 2.1 Global Reported Incidents of Drug Counterfeiting, 2008-2012
Figure 2.2 Flow Chart of the Route Taken by Counterfeit Pharma Products Entering the Legal
Supply Chain
Figure 3.1 Holograms Anti-counterfeiting Technologies: Drivers and Restraints, 2014-2024
Figure 3.2 Basic Components of a RFID System
Figure 3.3 RFID Anti-counterfeiting Technologies: Drivers and Restraints, 2014-2024
Figure 3.4 Taggants Anti-counterfeiting Technologies: Drivers and Restraints, 2014-2024
Figure 3.5 Barcode Anti-counterfeiting Technologies: Drivers and Restraints, 2014-2024
Figure 4.1 3M: Revenue Shares (%) by Business Segment, 2012
Figure 4.2 Authentix’s Global Monitoring Service: A Three Step Program
Figure 4.3 Avery Dennison: Revenue Shares (%) by Business Segment, 2012
Figure 4.4 InkSure Technologies: Historical Revenue ($m) 2009-2012
Figure 4.5 Intermec: Historical Revenue ($m) 2009-2012
Figure 4.6 ThermoFisher Scientific: Historical Revenue ($bn) 2009-2012
Figure 4.7 ThermoFisher Scientific: Revenue Shares (%) by Region, 2012
Figure 4.8 Zebra Technologies: Historical Revenue ($m) 2009-2012
Figure 5.1 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Revenues ($m) by
Sector, 2012
Figure 5.2 The Global Pharmaceutical Anti-counterfeiting Technologies: Revenue Forecast ($m),
2012- 2017
Figure 5.3 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Revenue Forecast
($m), 2017-2024
Figure 5.4 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Revenue ($m) by
Sector, 2012, 2017, 2024
Figure 5.5 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%)
by Sector, 2012
by Sector, 2017

www.visiongain.com

Contents
by Sector, 2024
Figure 5.8 RFID: Revenue Forecast ($m), 2012-2024
Figure 5.9 Security Printing: Revenue Forecast ($m), 2012-2024
Figure 5.10 Pharmaceutical Taggants: Revenue Forecast ($m), 2012-2024
Figure 5.11 Holograms/OVD: Revenue Forecast ($m), 2012-2024
Figure 5.12 Other Technologies Revenue Forecast ($m), 2012-2024
Figure 6.1 US and EU5 Pharmaceutical Anti-counterfeiting Technologies: Revenue Forecast ($m),
2012-2024
Figure 6.2 China, India, Brazil and Russia Pharmaceutical Anti-counterfeiting Technologies Market:
Revenue Forecast ($m), 2012-2024
by Region, 2012
by Region, 2017
by Region, 2024
Figure 6.6 US Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m), 2012-2024
Figure 6.7 EU5 Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m), 2012-2024
Figure 6.8 Japanese Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m), 20122024
Figure 6.9 Chinese Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m), 2012-2024
Figure 6.10 Indian Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m), 2012-2024
Figure 6.11 Brazilian Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m), 20122024
Figure 6.12 Russian Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m), 2012-2024
Figure 7.1 EU Supply Chain Authentication Strategy, 2013
Figure 7.2 US Supply Chain Authentication Strategy, 2013
Figure 9.1 Global Pharmaceutical Anti-counterfeiting Market: RFID, Security Printing,
Holograms/OVD, and Taggants Revenue Forecast ($m), 2012-2024

www.visiongain.com

Contents
Organisations Mentioned in this Report
3M
Adhesives Research
Ahura Scientific
Alien Technologies
AlpVision
Altegrity Risk International
American Academy of Pediatrics (AAP)
American Express
AmerisourceBergen
Angstrom Technologies
Anti-Counterfeiting and Product Protection Programme (A-CAPPP)
Anti-Counterfeiting Group (ACG)
Apoteket
Applied DNA Sciences
ARmark Authentication Technologies LLC
AstraZeneca
Australian Therapeutic Goods Administration (TGA)
Authentix
Automation
Avery Dennison
Axway
Baxter
Canadian Anti-Counterfeiting Network (CACN)
Capsugel
Cellular Bioengineering Inc.
Center for Healthcare Supply Chain Research
Center for Medicine in the Public Interest (US)
CFC International

www.visiongain.com

Contents
Chesapeake
Colorcon
Cortegra
Covectra
Digital China
Directorate General of Foreign Trade [India]
Domino
Drugs Standard Control Organisation
DuPont
European Alliance for Access to Safe Medicines (EAASM)
European Commission
European Directorate for the Quality of Medicines and Healthcare (EDQM),
European Federation of Pharmaceutical Industries and Associations (EFPIA)
European Medicines Agency
Europol
Everest Holovisions
GlaxoSmithKline (GSK)
Google
Healthcare Distribution Management Association (HDMA)
Heart UK
Hologram Industries
Holomex
HOMAI (hologram manufactures association of India)
Honeywell International
Image Solutions
Impinj Inc
Ingenia Technology
InkSure Technologies
Intermec/ Interface Mechanisms
International Anti-counterfeiting Association (IAA)

www.visiongain.com

Contents
International Anti-Counterfeiting Coalition (IACC)
International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
International Ink Company
International Medical Products Anti-Counterfeiting Taskforce (IMPACT)
International Policy Network
Interpol
Japanese Pharmaceutical Manufacturers Association (JPMA)
Johnson & Johnson
Kodak
Loughborough University
LaserLock
Massachusetts Institute of Technology (MIT)
MasterCard
Medicines and Healthcare products Regulatory Agency (MHRA)
Medicrime Convention Council
Menasha Corporation
MicroTag Temed Ltd
Microtrace Solutions
Motorola
NanoGuardian
NanoInk Inc.
Nanotech Security Corp.
National Agency for Food and Drug Administration and Control (NAFDAC) [Nigeria]
National Association of Boards of Pharmacy (NABP)
National Health Surveillance Agency (ANVISA)
Neri Labels
Novartis
Novavision
OEP Technologie BV
One Equity Partners
OpSec Security

www.visiongain.com

Contents
Organisation for Economic Co-operation and Development (OECD)
Pacific Holographics
Paralec Inc
Partner for Safe Medicines (PSM) India
Pera Innovations
Pfizer
Pharmaceutical Research and Manufacturers of America (PhRMA)
PharmaSecure
Quality Brands Protection Committee (QBPC) [China]
Reckitt Benckiser
Roche
Royal Pharmaceutical Society of Great Britain (RPSGB)
Sanofi
Savi Technology
ScanSource
Scientific Protein Laboratories (SPL)
SICPA
Siemens
Smartrac
South Dakota School of Mines and Technology
State Food and Drug Administration (SFDA) [China]
Sun Chemical
Symbol Technologies
Systech
Tagsys RFID
Teva Pharmaceuticals
Texas Instruments
The Caryle Group
The International Hologram Manufacturers Association
The Patients Association (UK)
The Pharmaceutical Security Institute (PSI)

www.visiongain.com

Contents
ThermoFisher Scientific
TruTag Technologies
United Nations
University of South Dakota
UPM
UPM Kymmene
UPM Raflatac
UPM Rafsec z
US Center for Safe Internet Pharmacies (CSIP).
US Food and Drugs Agency (FDA)
US Pharmacopeial Convention (USP)
Visa
Vocollect Inc
Voxtel
Webscan
World Customs Organization
World Health Organization (WHO)
World Intellectual Property Organization (WIPO)
Zebra Technologies

www.visiongain.com

Pharmaceutical Anti-counterfeiting Technologies:
Market Analysis 2014-2024
Passive RFID tags operate without a separate external power source and obtain operating power
generated from the reader. Passive tags are consequently much lighter than active tags, less
expensive, and offer a virtually unlimited operational lifetime. The trade off is that they have shorter
read ranges than active tags and require a higher-powered reader. Read-only tags are typically
passive and are programmed with a unique set of data (usually 32 to 128 bits) that cannot be
modified. Read-only tags most often operate as a licence plate into a database, in the same way
as linear barcodes reference a database containing modifiable product-specific information.

Figure 3.3 RFID Anti-counterfeiting Technologies: Drivers and Restraints, 2014-2024

Restraints

Drivers
•

•

Supply chain tracking capabilities,
now promoted by many regulatory
authorities
High level of security against
duplication

•

Tags can be read at distance

•

Wireless capabilities means
identification is possible without the
need to physically see the tag

•

RFID tags may contain personal
information – potential for exposure
of personal information

•

Generally a high cost technology

•

Requirement for specialized
readers

•

Reliability, radio waves are
deflected or impeded by certain
materials interfering with signals

Source: Visiongain 2013

The significant advantage of all types of RFID systems is the fact that authentication can be done
remotely as the technology does not require contact between reader and tag (Figure 3.3). Tags
can be read through a variety of substances such as snow, fog, ice, paint, dirt and other visually
and environmentally challenging conditions, where barcodes or other optically read technologies
would be useless. RFID tags can also be read in challenging circumstances at high speeds, in
most cases responding in less than 100 milliseconds. The read/write capability of an active RFID
system is also a significant advantage in interactive applications such as work-in-process or
maintenance tracking. Although it is a costlier technology (compared with barcodes), RFID has
become indispensable for a wide range of automated data collection and identification applications.
Table 3.4 summarises the leading global manufacturers of RFID tags.

www.visiongain.com

Page 48

Table 4.16 Zebra Technologies: Product Groups and Descriptions, 2013
Technology Sector

Description
For UHF RFID and HF RFID in the supply chain and for other
applications

Passive RFID

Encoded smart labels are printable labels embedded with an
ultra-thin radio frequency transponder. Information encoded in
these transponders can then be read and modified by a radio
frequency reader. These labels eliminate the need of a visual ID
of a barcode, as the ID signal is transmitted by radio frequency
Falls under the branch of location solutions, software and
hardware are used to locate, track, manage, and improve
operational functions

Active RFID

Zebra’s location solutions include asset tags, call tags,
sensors, exciters and application software.
Active RFID products include, DartTag, WhereTag and
WhereCall, incorporating various Real Time Locating System
(RTLS) technologies based on ultra-wide band (UWB),
WhereNet and Wi-Fi active RFID

Thermal barcode
technology

Barcode printers with thermal-transfer and direct thermal
technology produce accurate, high-quality images.

Source: Zebra Technologies 2013, Visiongain 2013

The company operates within two branches – printing operations and location solutions. Within
these branches the company’s product range consists of direct thermal and thermal transfer label
and receipt printers, passive radio frequency identification (RFID) printer/encoders and dye
sublimation card printers. They also sell specialty supplies consisting of self-adhesive labels,
thermal transfer ribbons, thermal print-heads, batteries and other accessories, including software
for label design and printer network management. Some of the technology branches and their
applications are detailed in Table 4.16.

It is difficult to estimate the company’s contribution to the pharmaceutical anti-counterfeiting sector
because operations are spread over a range of industries. However, it is clear that Zebra
Technologies is an industry leader in printing solutions to identify, authenticate, track-and-trace
products. The company’s revenue in 2012 was $996.2m, which represents an increase of 1.3%
from the previous year (Table 4.17 and Figure 4.8).

www.visiongain.com

Page 81

Table 5.9 Holograms/OVD: Revenue Forecast ($m, AGR%, CAGR%), 2012-2024

2012
Hologram/OVD ($m)
Annual Growth (%)
CAGR (% 2012-2017 &
2017-2024)
CAGR (% 2012-2024)

2013

2014

2015

80.7

85.5
6

90.6
6

97.9 105.7 113.1 121.0 127.1 133.4 140.1 148.5 155.9 162.2
8
8
7
7
5
5
5
6
5
4

2016

2017

2018

2019

2020

2021

2022

2023

7.0

2024

5.3
6.0


Figure 5.11 Holograms/OVD: Revenue Forecast ($m), 2012-2024
180
155.9

160
140.1

Revenue ($m)

140

127.1

100
80

133.4

113.1

120
97.9

85.5

162.2
148.5

121.0
105.7

90.6
80.7

60
40
20
0
2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Year


Holograms and optically variable devices fall into the category of overt technologies. Although they
offer a relatively easy platform of anti-counterfeiting technology to implement – low cost and ease
in which they can be applied, in recent years the risk of imitation has risen. Visiongain believes that
potential security breaches and the strong growth of track-and-trace technologies (traditionally not
holograms/OVD) will ultimately slow the growth of hologram/OVD market and reduce its market
share. However, overall the hologram market will continue to see slow growth. Like most other
sub-markets, growth in the pharmaceutical holograms market will be driven by pharmaceutical

www.visiongain.com

Page 99

8. Expert Opinions
8.1 Interview with Dr Fred Jordan, Chief Executive Officer, AlpVision
In October 2013, visiongain interviewed Dr Fred Jordan (FJ), the chief executive officer of
AlpVision. Topics discussed include AlpVision’s key technologies and the advancements in anticounterfeiting technologies, the increasing sophistication of counterfeiting criminals, and the main
barriers and threats facing the implementation of anti-counterfeiting technologies.
We thank Dr Jordan for his time and opinion.

8.1.1 Current State of Counterfeiting in the Pharmaceutical Industry
Visiongain: How severe would you say the counterfeiting situation is within the pharmaceutical
industry, and how do you see this changing in the next decade?

FJ: Judging as a technology provider based on the number of requests we get from the
pharmaceutical industry, if you take the top 50 pharmaceutical companies, I don’t know of any of
these companies who have absolutely no anti-counterfeiting efforts; so all of them are doing
something at some level. There are some exceptions for pharma companies who are only
manufacturing generics. Looking at the interests of these companies gives an extent of the severity
of the problem.

Visiongain: Based on the information you have, where in the globe do you think the biggest
counterfeiting threats lie?

FJ: I don’t know where the biggest threat is, but what I know is from which companies we get the
most requests. These are mainly European and US based companies.

8.1.2 AlpVison’s Key Technologies and Strategies for Combating
Counterfeiters
Visiongain: Could you give us an insight into AlpVision’s key technologies, especially those
geared towards combating pharmaceutical anti-counterfeiting?

FJ: Firstly, all the technologies that we have are dedicated to combating counterfeiting. We have
two technologies: one is a printed technology which is appropriate for labels and packages. The
other technology is for moulded plastic like caps, bottles, syringes and other moulded items. These
are both used in the pharma field.

www.visiongain.com

Page 155

Pharmaceutical Anti Counterfeiting Technologies 2014-2024

Recommended

Recommended

More Related Content

Recently uploaded

Recently uploaded (20)

Featured

Featured (20)

Pharmaceutical Anti Counterfeiting Technologies 2014-2024